Author Hüll, Michael

• 1994 | Journal Article | Research Paper
  ​ ​REGULATION OF IMMEDIATE-EARLY GENE-EXPRESSION IN RAT RETINAL GANGLION-CELLS AFTER AXOTOMY AND DURING REGENERATION THROUGH A PERIPHERAL-NERVE GRAFT​
  Hüll, M. & Bähr, M. ​ (1994) 
  Journal of Neurobiology, 25(1) pp. 92​-105​.​ DOI: https://doi.org/10.1002/neu.480250109 
  ​Details  DOI  PMID  PMC  WoS 

• 1994 | Journal Article | Research Paper
  ​ ​DIFFERENTIAL REGULATION OF C-JUN EXPRESSION IN RAT RETINAL GANGLION-CELLS AFTER PROXIMAL AND DISTAL OPTIC-NERVE TRANSECTION​
  Hüll, M. & Bähr, M. ​ (1994) 
  Neuroscience Letters, 178(1) pp. 39​-42​.​ DOI: https://doi.org/10.1016/0304-3940(94)90284-4 
  ​Details  DOI  PMID  PMC  WoS 

• 2010 | Journal Article | 
  ​ ​Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease​
  Jones, L.; Holmans, P. A.; Hamshere, M. L.; Harold, D.; Moskvina, V.; Ivanov, D. & Pocklington, A. et al.​ (2010) 
  PLoS ONE, 5(11) art. e13950​.​ DOI: https://doi.org/10.1371/journal.pone.0013950 
  ​Details  DOI  PMID  PMC 

• 2014 | Journal Article
  ​ ​SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease​
  Ramirez, A.; van der Flier, W. M.; Herold, C.; Ramonet, D.; Heilmann, S.; Lewczuk, P.   & Popp, J. et al.​ (2014) 
  Human Molecular Genetics, 23(24) pp. 6644​-6658​.​ DOI: https://doi.org/10.1093/hmg/ddu372 
  ​Details  DOI 

• 2015 | Journal Article
  ​ ​Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI​
  Wolfsgruber, S.; Jessen, F.; Koppara, A.; Kleineidam, L.; Schmidtke, K.; Frölich, L. & Kurz, A. et al.​ (2015) 
  Neurology, 84(12) pp. 1261​-1268​.​ DOI: https://doi.org/10.1212/wnl.0000000000001399 
  ​Details  DOI 

• 2015 | Journal Article | 
  ​ ​PLD3 in non-familial Alzheimer's disease​
  Heilmann, S.; Drichel, D.; Clarimon, J.; Fernández, V.; Lacour, A.; Wagner, H. & Thelen, M. et al.​ (2015) 
  Nature, 520(7545) pp. E3​-E5​.​ DOI: https://doi.org/10.1038/nature14039 
  ​Details  DOI 

• 2015 | Journal Article | 
  ​ ​Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study​
  Morgen, K.; Schneider, M.; Frölich, L.; Tost, H.; Plichta, M. M.; Kölsch, H. & Rakebrandt, F.  et al.​ (2015) 
  Alzheimer's Research & Therapy, 7(1).​ DOI: https://doi.org/10.1186/s13195-015-0111-8 
  ​Details  DOI 

• 2015 | Journal Article
  ​ ​Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type​
  Popp, J.; Wolfsgruber, S.; Heuser, I.; Peters, O.; Hüll, M.; Schröder, J. & Möller, H.-J. et al.​ (2015) 
  Neurobiology of Aging, 36(2) pp. 601​-607​.​ DOI: https://doi.org/10.1016/j.neurobiolaging.2014.10.031 
  ​Details  DOI  PMID  PMC 

• 2016 | Journal Article
  ​ ​No association of the variant rs11887120 in DNMT3A with cognitive decline in individuals with mild cognitive impairment​
  Bey, K.; Wolfsgruber, S.; Karaca, I.; Wagner, H.; Lardenoije, R.; Becker, J. & Milz, E. et al.​ (2016) 
  Epigenomics, 8(5) pp. 593​-598​.​ DOI: https://doi.org/10.2217/epi-2015-0014 
  ​Details  DOI 

• 2016 | Journal Article
  ​ ​The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment​
  Koppara, A.; Wolfsgruber, S.; Kleineidam, L.; Schmidtke, K.; Frölich, L.; Kurz, A. & Schulz, S. et al.​ (2016) 
  Journal of Alzheimer's Disease, 49(2) pp. 547​-560​.​ DOI: https://doi.org/10.3233/jad-150257 
  ​Details  DOI 

• 2016 | Journal Article
  ​ ​Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment​
  Louwersheimer, E.; Wolfsgruber, S.; Espinosa, A.; Lacour, A.; Heilmann-Heimbach, S.; Alegret, M. & Hernández, I. et al.​ (2016) 
  Alzheimer's & Dementia, 12(8) pp. 872​-881​.​ DOI: https://doi.org/10.1016/j.jalz.2016.01.006 
  ​Details  DOI 

• 2017 | Journal Article | 
  ​ ​Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia​
  Frölich, L.; Peters, O.; Lewczuk, P. ; Gruber, O. ; Teipel, S. J.; Gertz, H. J. & Jahn, H. et al.​ (2017) 
  Alzheimer's Research & Therapy, 9(1) art. 84​.​ DOI: https://doi.org/10.1186/s13195-017-0301-7 
  ​Details  DOI 

• 2017 | Journal Article
  ​ ​Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment​
  Wolfsgruber, S.; Polcher, A.; Koppara, A.; Kleineidam, L.; Frölich, L.; Peters, O. & Hüll, M. et al.​ (2017) 
  Journal of Alzheimer's Disease, 58(3) pp. 939​-950​.​ DOI: https://doi.org/10.3233/JAD-161252 
  ​Details  DOI  PMID  PMC  WoS 

• 2018 | Journal Article
  ​ ​Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes​
  Espinosa, A.; Hernández-Olasagarre, B.; Moreno-Grau, S.; Kleineidam, L.; Heilmann-Heimbach, S.; Hernández, I. & Wolfsgruber, S. et al.​ (2018) 
  Frontiers in Aging Neuroscience, 10.​ DOI: https://doi.org/10.3389/fnagi.2018.00340 
  ​Details  DOI 

• 2019 | Journal Article | 
  ​ ​A rare heterozygous TREM2 coding variant identified in familial clustering of dementia affects an intrinsically disordered protein region and function of TREM2​
  Karsak, M.; Glebov, K.; Scheffold, M.; Bajaj, T.; Kawalia, A.; Karaca, I. & Rading, S. et al.​ (2019) 
  Human Mutation, 41(1) pp. 1​-13​.​ DOI: https://doi.org/10.1002/humu.23904 
  ​Details  DOI 

• 2019 | Journal Article | Research Paper | 
  ​ ​A combined miRNA–piRNA signature to detect Alzheimer’s disease​
  Jain, G.; Stuendl, A.; Rao, P.; Berulava, T.; Pena Centeno, T.; Kaurani, L.   & Burkhardt, S.  et al.​ (2019) 
  Translational Psychiatry, 9(1).​ DOI: https://doi.org/10.1038/s41398-019-0579-2 
  ​Details  DOI  PMID  PMC 

• 2020 | Journal Article
  ​ ​Association of a CAMK2A genetic variant with logical memory performance and hippocampal volume in the elderly​
  Rhein, C.; Mühle, C.; Lenz, B.; Richter-Schmidinger, T.; Kogias, G.; Boix, F. & Lourdusamy, A. et al.​ (2020) 
  Brain Research Bulletin, 161 pp. 13​-20​.​ DOI: https://doi.org/10.1016/j.brainresbull.2020.05.001 
  ​Details  DOI 

• 2020 | Journal Article | 
  ​ ​PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment​
  Kleineidam, L.; Chouraki, V.; Próchnicki, T.; van der Lee, S. J.; Madrid-Márquez, L.; Wagner-Thelen, H. & Karaca, I. et al.​ (2020) 
  Acta Neuropathologica, 139(6) pp. 1025​-1044​.​ DOI: https://doi.org/10.1007/s00401-020-02138-6 
  ​Details  DOI 

• 2021 | Journal Article
  ​ ​Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments​
  Ophey, A.; Wolfsgruber, S.; Roeske, S.; Polcher, A.; Spottke, A.; Frölich, L. & Hüll, M. et al.​ (2021) 
  Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 13(1).​ DOI: https://doi.org/10.1002/dad2.12223 
  ​Details  DOI 

• 2022 | Journal Article | 
  ​ ​Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network​
  Benson, G. S.; Bauer, C.; Hausner, L.; Couturier, S.; Lewczuk, P.; Peters, O. & Hüll, M. et al.​ (2022) 
  Journal of Neural Transmission,.​ DOI: https://doi.org/10.1007/s00702-022-02461-0 
  ​Details  DOI 

Researcher

Sort

Items per Page